DAOIB
Sponsors
Chang Gung Memorial Hospital
Conditions
Behavioral and Psychological Symptoms in Alzheimer's DiseaseBehavioral and Psychological Symptoms in Vascular DementiaDementiaLong COVIDMild Cognitive ImpairmentTranscranial Direct Current Stimulation
Phase 2
DAOIB for the Treatment of Cognitive Function and Behavioral and Psychological Symptoms of Dementia
CompletedNCT02103673
Start: 2014-02-28End: 2017-11-30Updated: 2018-01-24
NMDA-enhancing Agent for the Treatment of Mild Cognitive Impairment
CompletedNCT02239003
Start: 2012-01-31End: 2017-12-31Updated: 2018-01-24
DAOIB for the Treatment of Mild Cognitive Impairment
CompletedNCT04736355
Start: 2020-01-01End: 2024-06-30Updated: 2024-08-21
DAOIB Combined With tDCS for Early-phase Dementia
CompletedNCT04737096
Start: 2020-01-01End: 2023-01-02Updated: 2023-01-06
The Dose Finding Study of DAOIB Added to tDCS for AD
SuspendedNCT05006781
Start: 2027-01-01End: 2028-12-01Target: 140Updated: 2026-03-20
Efficacy Biomarkers of DAOIB for Dementia
RecruitingNCT05582161
Start: 2022-10-03End: 2026-09-01Target: 123Updated: 2026-03-19
DAOIB for the Treatment of Brain Fog
RecruitingNCT05764538
Start: 2023-02-27End: 2026-06-01Target: 40Updated: 2026-03-19